Case number 1:18-cv-00757
Astellas Pharma Inc. et al v. Eugia Pharma Specialities Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 5, 2019 | 52 | Patent/Trademark Report to Commissioner (1) |
| Sep 5, 2019 | 52 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2 ;8,183,274 B2 ;9,126,941 B2. (Attachments: # (1) Dismissal Order)(fms) |
| Sep 5, 2019 | 52 | Dismissal Order (2) |
| Sep 5, 2019 | 51 | Order (2) Docket Text: DISMISSAL ORDER re [50] Stipulation of Dismissal, filed by Astellas Pharma US, Inc., Medivation Prostate Therapeutics LLC, Medivation LLC, Astellas Pharma Inc., Regents of the University of California, Astellas US LLC, ***Civil Case Terminated. Signed by Judge Colm F. Connolly on 9/4/2019. (fms) |
| Sep 3, 2019 | 50 | Order of Dismissal (2) |
| Sep 3, 2019 | 50 | Stipulation of Dismissal (1) |
| Sep 3, 2019 | 50 | Main Document (1) Docket Text: STIPULATION of Dismissal by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Order of Dismissal)(Fahnestock, Derek) |
| Aug 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [49] STIPULATION TO EXTEND TIME for the close of fact discovery and Defendants' Responses & Objections to Plaintiffs' Second Set of Requests for Admission (Nos. 13-15) to September 3, 2019 filed by Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd., Aurobindo Pharma Ltd. Signed by Judge Colm F. Connolly on 8/27/2019. (fms) |
| Aug 26, 2019 | 49 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the close of fact discovery and Defendants' Responses & Objections to Plaintiffs' Second Set of Requests for Admission (Nos. 13-15) to September 3, 2019 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Bilson, David) |
| Aug 20, 2019 | N/A | SO ORDERED (0) |
| Aug 19, 2019 | 48 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Discovery Deadlines to various (see stipulation) - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Fahnestock, Derek) |
| Aug 7, 2019 | N/A | SO ORDERED (0) |
| Aug 5, 2019 | 47 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Certain Discovery Deadlines to various (see stipulation) - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Fahnestock, Derek) |
| Jul 23, 2019 | N/A | SO ORDERED (0) |
| Jul 22, 2019 | 46 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Fact Discovery Deadlines to various dates (see Stipulation) - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Fahnestock, Derek) |
| Jun 28, 2019 | N/A | SO ORDERED (0) |
| Jun 27, 2019 | 45 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Fact Discovery Deadlines to various (see stipulation) - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Fahnestock, Derek) |
| Jun 7, 2019 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Objections to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) to Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Bilson, David) |
| May 29, 2019 | 43 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Admission (Nos. 13-15) to Defendants Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) |
| Apr 29, 2019 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-12) to Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Bilson, David) |
| Apr 23, 2019 | 41 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. on June 10, 2019 filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) |
| Mar 29, 2019 | 40 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-12) to Defendants Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) |
| Mar 5, 2019 | 39 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Joseph K. Yarsky as co-counsel. Reason for request: No longer with firm. (Fahnestock, Derek) |
| Feb 28, 2019 | N/A | SO ORDERED (0) |
| Feb 27, 2019 | 38 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadline for substantial completion of the production of documents in response to document requests to May 6, 2019 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Phillips, John) |
| Feb 25, 2019 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) to Eugia Pharma Specialties Ltd., Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.; and (2) Defendants' Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-42) to Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Bilson, David) |
| Jan 29, 2019 | 36 | Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Michael E. Furrow as co-counsel. Reason for request: No longer with firm. (Fahnestock, Derek) |
| Jan 24, 2019 | 35 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories (Nos. 1-9) to Defendants Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. and (2) Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-42) to Defendants Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) |
| Jan 22, 2019 | 34 | Scheduling Order (9) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/3/2019. Amended Pleadings due by 5/31/2019. Fact Discovery completed by 6/28/2019. Expert Discovery due by 12/20/2019. Proposed Pretrial Order due by 2/14/2020. A Final Pretrial Conference is set for 3/10/2020 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 3/23/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/22/2019. (nmf) |
| Jan 18, 2019 | 33 | Proposed Order (9) |
| Jan 18, 2019 | 33 | Cover Letter (1) |
| Jan 18, 2019 | 33 | Main Document (9) Docket Text: PROPOSED ORDER /Joint Proposed Scheduling Order by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Cover Letter)(Fahnestock, Derek) |
| Jan 4, 2019 | 32 | Order (1) Docket Text: ORDER, IT IS ORDERED that, on or before January 18, 2019, the Plaintiffs shall submit a proposed revised scheduling order that incorporates the dates and discovery limitations currently in effect and comports with the Court's "Rule 16 Scheduling Order for Patent Cases"(revised on November 14, 2018) except that the Markman hearing shall be scheduled for Wednesday, June 5, 2019 at 9:00 a.m. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/18/2019.) Signed by Judge Colm F. Connolly on 1/4/2019. (nmf) |
| Nov 30, 2018 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Invalidity Contentions on behalf of Eugia Pharma Specialties Ltd., Aurobindo Pharma USA, Inc. and Aurobindo Pharma, Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Bilson, David) |
| Nov 27, 2018 | 30 | Notice of Substitution of Counsel (1) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.: Entry of appearance of attorney John C. Phillips, Jr. Attorney Benjamin J. Schladweiler terminated. (Phillips, John) |
| Nov 6, 2018 | 29 | Notice (Other) (4) Docket Text: NOTICE of Change of Law Firm Name and E-mail Addresses by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California (Fahnestock, Derek) |
| Nov 1, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joseph Schramm, III,Gary Ji for Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Oct 30, 2018 | N/A | SO ORDERED (0) |
| Oct 29, 2018 | 28 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph Schramm, III and Gary Ji - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Schladweiler, Benjamin) |
| Oct 24, 2018 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions Against Eugia Pharma Specialities LTD., Aurobindo Pharma USA, Inc., and Aurobindo Pharma LTD filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) |
| Oct 3, 2018 | 26 | Status Report (3) |
| Oct 3, 2018 | 26 | Exhibit A (9) |
| Oct 3, 2018 | 26 | Main Document (3) Docket Text: Joint STATUS REPORT by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Exhibit A)(Fahnestock, Derek) |
| Oct 1, 2018 | 25 | Order (3) Docket Text: ORDER: IT IS ORDERED that on or before October 22, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, information requested regarding ADR. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/1/18. (cak) |
| Sep 25, 2018 | N/A | SO ORDERED (0) |
| Sep 24, 2018 | 24 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME for Defendants to produce their core technical documents to October 1, 2018 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Schladweiler, Benjamin) |
| Sep 20, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before October 4, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. (Status report due 10/4/2018.) Ordered by Judge Colm F. Connolly on September 20, 2018. (nmf) |
| Sep 20, 2018 | N/A | Case Reassigned to CFC (0) Docket Text: Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:16-cv-01120-CFC, 1:16-cv-01167-CFC, 1:17-cv-00542-CFC, 1:18-cv-00757-CFC (rjb) |
| Sep 11, 2018 | N/A | SO ORDERED (0) |
| Sep 6, 2018 | 23 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde, William E. Solander, Michael E. Furrow, Erin J.D. Austin, Whitney L. Meier, Gregory J. Manas, Madhundra Sivakumar and Joseph K. Yarsky - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Fahnestock, Derek) |
| Sep 6, 2018 | N/A | SO ORDERED (0) |
| Sep 4, 2018 | 22 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Schladweiler, Benjamin) |
| Aug 24, 2018 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Paragraph 3 of the Court's ESI Default Standard for Discovery on Behalf of Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Schladweiler, Benjamin) |
| Aug 24, 2018 | 20 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Default Standard Disclosures filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) |
| Aug 24, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (fms) |
| Aug 23, 2018 | N/A | SO ORDERED (0) |
| Aug 8, 2018 | 19 | Cover Letter (1) |
| Aug 8, 2018 | 19 | Proposed Order (7) |
| Aug 8, 2018 | 19 | Main Document (7) Docket Text: PROPOSED ORDER /Scheduling Order by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Cover Letter)(Fahnestock, Derek) |
| Aug 2, 2018 | 18 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amended Initial Disclosures of Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Schladweiler, Benjamin) |
| Aug 2, 2018 | N/A | SO ORDERED (0) |
| Aug 1, 2018 | N/A | Oral Order (0) |
| Aug 1, 2018 | 16 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Blumenfeld, Jack) |
| Aug 1, 2018 | 17 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc., and Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Schladweiler, Benjamin) |
| Jul 31, 2018 | 15 | Proposed Order (22) Docket Text: PROPOSED ORDER -- Stipulated Protective Order -- by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Blumenfeld, Jack) |
| Jul 24, 2018 | 14 | Exhibit A--Proposed Scheduling Order (8) |
| Jul 24, 2018 | 14 | Status Report (11) |
| Jul 24, 2018 | 14 | Main Document (11) Docket Text: Joint STATUS REPORT by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Exhibit A--Proposed Scheduling Order)(Fahnestock, Derek) |
| Jul 19, 2018 | N/A | SO ORDERED (0) |
| Jul 18, 2018 | 13 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for the parties to file a joint status report and proposed scheduling order to August 1, 2018 - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Fahnestock, Derek) |
| Jul 12, 2018 | N/A | SO ORDERED (0) |
| Jul 10, 2018 | 12 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME for the parties to file a joint status report and proposed scheduling order to July 18, 2018 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Schladweiler, Benjamin) |
| Jun 28, 2018 | 11 | Answer to Counterclaim (6) Docket Text: ANSWER to [8] Answer to Complaint, Aurobindo Pharma USA Inc.'s Counterclaims by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California.(Fahnestock, Derek) Modified on 7/12/2018 (mdb). |
| Jun 11, 2018 | 10 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 6/11/2018. (asw) |
| Jun 8, 2018 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Curepro Parenterals Limited, Other Affiliate Celon Laboratories Private Limited for Eugia Pharma Specialities Ltd.; Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc.; Corporate Parent Curepro Parenterals Limited for Aurobindo Pharma Ltd. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd.. (Schladweiler, Benjamin) |
| Jun 8, 2018 | 8 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd..(Schladweiler, Benjamin) |
| May 23, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (nms) |
| May 21, 2018 | 7 | Exhibits A-B (5) |
| May 21, 2018 | 7 | Declaration (2) |
| May 21, 2018 | 7 | Main Document (2) Docket Text: DECLARATION of Mailing Summons, Complaint and related papers on Eugia Pharma Specialities Ltd. by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Exhibits A-B)(Fahnestock, Derek) Modified on 7/30/2018 (mdb). |
| May 18, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Astellas Pharma US, Inc., Astellas Pharma Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. Aurobindo Pharma USA, Inc. served on 5/18/2018, answer due 6/8/2018. (Fahnestock, Derek) |
| May 17, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 5/17/2018; Aurobindo Pharma USA, Inc. on 5/17/2018; Eugia Pharma Specialities Ltd. on 5/17/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| May 17, 2018 | 1 | Main Document (18) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2384041.) - filed by Astellas Pharma US, Inc., Astellas Pharma Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(fms) |
| May 17, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Pfizer Inc. for Medivation LLC; Other Affiliate Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC; identifying none for Astellas Pharma Inc.; identifying none for Regents of the University of California; identifying Other Affiliate Medivation LLC for Medivation Prostate Therapeutics LLC; filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC, Medivation LLC, Medivation Prostate Therapeutics LLC, Regents of the University of California. (fms) |
| May 17, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2 ;8,183,274 B2 ;9,126,941 B2. (fms) |
| May 17, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/13/2018. Date of Expiration of Patent: See form.Thirty Month Stay Deadline: 10/13/2020. (fms) |
| May 17, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| May 17, 2018 | 1 | Civil Cover Sheet (1) |
| May 17, 2018 | 1 | Exhibit A (296) |
| May 17, 2018 | 1 | Complaint (18) |
| May 17, 2018 | 1 | Complaint* (1) |
